Le Lézard
Classified in: Health, Science and technology, Business
Subjects: FNC, PDT

Healables Launches $4.8M CrowdFunding Campaign, Mobilizing People to Transform Human Health and Performance with AI Personalized BioElectric Wearables


This CrowdFunding campaign offers retail investors shares in Healables ahead of expansion plans this coming year.

MIAMI, Oct. 19, 2023 /PRNewswire/ -- Healables (https://invest-in.healables.com), a world leader in wearable digital health technology, today announced the launch of a $4.8M CrowdFunding Campaign to bring AI personalized health to athletes and patients. "We're excited to offer this opportunity for physical therapists, athletes, trainers and coaches, and other retail investors to back our company on a mission to transform human health. The company that's going to do that is Healables" said Moshe Lebowitz, Co-Founder and CEO of Healables Digital Health, Inc.

"Health is broken. Not just in America, but all over the world. And it's broken because the one-size-fits-all approach does not meet the needs of the individual. We have built the team and the product that delivers personalized performance and will deliver personalized medicine" said Dr. George Lowell, MD, Healables' Co-Founder, Lead Investor, and Chief Science Officer of Healables and a Retired Colonel in the U.S. Army.

Dr. Lowell is a biotech entrepreneur with a previous successful exit. The Healables team includes medical doctors in sports medicine and pain management, and AI data scientists, electrical engineers and experts in material science, product development and user experience from Harvard University, Johns Hopkins University, MIT and other leading universities.

The secret sauce of Healables technology is the novel way that the company delivers microcurrents. Microcurrent technology has been researched in over 175 published peer-reviewed medical papers. The problem with microcurrents has been that until now, use of the technology required highly skilled professionals with a lot of hands-on time and cumbersome sticky, gooey, disposable electrodes that practically immobilized the patient.

Healables Electron Stream technology unites three patent-pending innovations that make microcurrent technology smart and accessible. First, smart textiles with built-in dry electrodes allow users to put the wearables on by themselves with complete mobility and comfort. Second, smart sessions leverage AI to enable data-driven personalization, optimized for each person. And third, remote smart time management allows both practitioners and users hands-off freedom because sessions can be monitored and modulated from anywhere at any time.

Funds from the crowdfunding campaign will help the company scale ElectroGear, its sports performance and recovery product line, and advance its medical technology through clinical trials focusing on non-opioid and non-steroidal solutions for musculoskeletal, pain and inflammation disorders.

As Dr. Lowell said, "It's a great feeling knowing that you can help people. We invite you to join us."

About Healables

Healables (Healables Digital Health, Inc.), is an AI Health Technology company on a mission to transform human health, performance and recovery with personalized, bioelectric wearables. Healables is the inventor of Electron Stream Microcurrent Technology which is currently being commercialized in three verticals: Sports, Automotive and Medicine, with ElectroGear Sports, ElectroGear Automotive and Medical, with an emphasis on non-steroidal and non-opioid solutions for musculoskeletal, inflammation and pain relief. Healables' senior leadership team comprises medical professionals, engineers and product developers with decades of combined industry experience. Healables Digital Health, Inc. is headquartered in Miami, Florida.

Press Contact:
Yasha Harari
Chief Marketing Officer
Healables Digital Health, Inc.
Phone: +1 (305) 547-9669
Web: https://invest-in.healables.com

Video - https://www.youtube.com/watch?v=xmAXm78BH98

SOURCE Healables Digital Health


These press releases may also interest you

16 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...

16 mai 2024
Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Velan Inc. ("Velan" or the "Company"), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless...

16 mai 2024
TSX VENTURE COMPANIES BULLETIN V2024-1467 DECISIVE DIVIDEND CORPORATION ("DE")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  May 16, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend per common share:...

16 mai 2024
CHICANE CAPITAL II CORP. (the "Corporation") is pleased to announce the filing of a final prospectus for its initial public offering. Access to the prospectus and any amendment thereto is provided in connection with the Corporation's initial public...



News published on and distributed by: